Carisoprodol is a centrally acting skeletal muscle relaxant and Schedule IV controlled substance; compounded preparations are made to a prescriber's order.
Carisoprodol is not marketed as a salt: the Soma label gives carisoprodol's chemical name, (±)-2-methyl-2-propyl-1,3-propanediol carbamate isopropylcarbamate, and its formula, C12H24N2O4, with no salt form. Carisoprodol is a skeletal muscle relaxant that acts on the central nervous system; its exact mechanism is not clearly identified, and its main metabolite, meprobamate, is believed to act at GABA receptors in a way similar to benzodiazepines. Soma tablets are FDA-approved for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults, for short periods only. A prescriber might order carisoprodol compounded when a needed form or vehicle is not manufactured. Compounded preparations are not FDA-approved and require a prescription.
Carisoprodol can cause drowsiness and dizziness and may impair driving or operating machinery. It has been subject to abuse, dependence, withdrawal, misuse and diversion; abuse can lead to overdose with CNS and respiratory depression, low blood pressure, seizures and death. Seizures have been reported, mostly with multiple-drug overdoses. Do not stop suddenly after large or prolonged use; withdrawal symptoms include insomnia, vomiting, abdominal cramps, headache, tremor, anxiety and hallucinations. Do not use it with acute intermittent porphyria or an allergy to carbamates such as meprobamate. Sedation adds up with alcohol, benzodiazepines, opioids and tricyclic antidepressants, and use with meprobamate is not recommended. CYP2C19 inhibitors (omeprazole, fluvoxamine) and inducers (rifampin, St. John's Wort) change its levels. Carisoprodol and meprobamate pass into breast milk, and sedation was reported in one breastfed infant. Get help right away for seizures or trouble breathing, and talk to your prescriber or pharmacist about other side effects.
Carisoprodol's muscle relaxant effect in animals is associated with altered interneuronal activity in the spinal cord and descending reticular formation. It is metabolized in the liver by CYP2C19 to meprobamate, which StatPearls describes as believed to act at GABA receptors similar to benzodiazepines and as contributing to therapeutic and abuse effects. Carisoprodol has a terminal half-life of about 2 hours and meprobamate about 10 hours; exposure is higher in females and in patients with reduced CYP2C19 activity, where the label advises caution. The Soma label limits use to short periods because evidence for longer use has not been established; safety and efficacy below age 16 are not established. Dosing is per prescriber. Monitor for sedation, misuse and withdrawal; StatPearls suggests periodic urine drug testing and pill counts. Carisoprodol is Schedule IV (21 CFR 1308.14). Electronic prescribing of controlled substances is voluntary under federal DEA rules; CMS applies a prescriber-level EPCS compliance threshold for Medicare Part D, and states may set their own requirements: Rhode Island, for example, requires electronic prescribing of Schedule II to V prescriptions.
Compounded at Bayview
Patient guides for the preparations we make most often. Each one is compounded to order and requires a prescription.
We do not have a patient page for this ingredient yet. That does not mean we cannot make it. Bayview compounds this ingredient to a prescriber's order, and our full compounding formulary lists every preparation we make. Viewing the formulary requires a prescriber account.
Prescriber sign inFor prescribers
Every preparation in our formulary that contains this ingredient. Strength, base and dose form are set by the prescription.
Other salt forms of this molecule, and ingredients commonly compounded alongside it.
This page describes an active pharmaceutical ingredient, not a finished drug product. Bayview Pharmacy compounds preparations containing it only on a prescriber's order for an individual patient.
Compounded preparations are not FDA-approved, and the FDA has not evaluated them for safety, effectiveness, or manufacturing quality. Nothing on this page is a claim that any preparation is effective for any condition.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Our pharmacists work with prescribers to build preparations around a patient's dose, form and tolerances. Ask us what is possible with this ingredient.